\-\ Texto\\:\\ \ \(0\)\
\-\ glucose\\ 132\\ mg\\/dl\\ \\(60\\-100\\)\ \(0\)\
\-\ bun\\ 11\\ mg\\/dl\\ \\(6\\-16\\)\ \(0\)\
\-\ creat\\ 0\\.6\\ mg\\/dl\\ \\(0\\.7\\-1\\.3\\)\ \(0\)\
\-\ na\\+\\ 140\\ mmol\\/l\\ \\(138\\-145\\)\ \(0\)\
\-\ k\\ 3\\.1\\ mmol\\/l\\ \\(3\\.6\\-5\\.2\\)\ \(0\)\
\-\ cl\\-\\ 98\\ mmol\\/l\\ \\(98\\-107\\)\ \(0\)\
\-\ co2\\ 28\\.7\\ mmol\\/l\\ \\(20\\-28\\)\ \(0\)\
\-\ ca\\ 7\\.9\\ mg\\/dl\\ \\(8\\.8\\-10\\.8\\)\ \(0\)\
\-\ ionized\\ ca\\ 0\\.87\\ mmol\\/l\\ \\(1\\.20\\-1\\.35\\)\ \(0\)\
\-\ ua\\:\\ glucose\\ 250\\ mg\\/dl\ \(0\)\
\-\ \\ \\ \\ \\ ketones\\ 15\\ mg\\/dl\ \(0\)\
\-\ \\ \\ \\ \\ prot\\ neg\ \(1\)\
\-\ ua\\ micro\\:\\ wbc\\ 5\\-10\\ hpf\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ rbc\\ 5\\-10\\ hpf\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ crystals\\ ca\\ oxalate\ \(0\)\
\-\ 24h\\ ua\\:\\ 1225\\ ml\\,\\ ca\\ 13\\ mg\\/dl\\,\\ ca\\ total\\ 159\\.25\\ mg\\/24\\ hr\ \(0\)\
\-\ phosphorus\\ 6\\.2\\ mg\\/dl\\ \\(2\\.4\\-4\\.6\\)\ \(0\)\
\-\ mg\\ 1\\.4\\ mg\\/dl\\ \\(1\\.6\\-2\\.4\\)\ \(0\)\
\-\ tsh\\ 0\\.829\\ mciu\\/ml\\ \\(0\\.35\\-4\\.94\\)\ \(0\)\
\-\ ft4\\ 1\\.03\\ ng\\/dl\\ \\(0\\.70\\-1\\.48\\)\ \(0\)\
\-\ hgb\\ 10\\.0\\ g\\/dl\\ \\(12\\.0\\-16\\.0\\)\ \(0\)\
\-\ hct\\ 31\\.1\\ \\%\\ \\(36\\.5\\-46\\.0\\)\ \(0\)\
\-\ 1\\,\\ 25\\-oh\\ vit\\ d\\ 41\\.7\\ pg\\/ml\\ \\(15\\.9\\-55\\.6\\)\ \(0\)\
\-\ pt\\ 16\\.3\\ sec\\ \\(12\\.0\\-14\\.2\\)\ \(0\)\
\-\ ptt\\ 31\\.4\\ sec\\ \\(23\\.7\\-33\\.8\\)\ \(0\)\
\-\ alk\\ phos\\ 307\\ units\\/l\\ \\(499\\)\ \(0\)\
\-\ ast\\ 103\\ units\\/l\\ \\(9\\-26\\)\ \(0\)\
\-\ alt\\ 57\\ units\\/l\\ \\(8\\-30\\)\ \(0\)\
\-\ amylase\\ 117\\ \\(32\\-107\\)\ \(0\)\
\-\ ldh\\ 339\\ units\\/l\\ \\(115\\-222\\)\ \(0\)\
\-\ cortcotpn\\ 67\\ pg\\/ml\\ \\(6\\-48\\)\ \(0\)\
\-\ no\\ follow\\-up\\ imaging\\ specifically\\ indicated\\ for\\ this\\ finding\\.\\ \\ medical\\ management\\ of\\ underlying\\ cause\\ of\\ medullary\\ nephrocalcinosis\\.\ \(0\)\
\-\ sagittal\\ ultrasonographic\\ images\\ of\\ the\\ right\\ kidney\\ demonstrate\\ diffusely\\ echogenic\\ pyramids\\ with\\ subtle\\ posterior\\ shadowing\\.\\ \\ the\\ size\\ of\\ the\\ right\\ kidney\\ is\\ at\\ the\\ lower\\ limits\\ of\\ normal\\.\\ \\ normal\\ renal\\ contour\\ is\\ observed\\ without\\ evidence\\ of\\ cortical\\ thinning\\ or\\ scarring\\.\ \(0\)\
\-\ medullary\\ nephrocalcinosis\ \(9\)\
\-\ medullary\\ nephrocalcinosis\\ caused\\ by\\:\ \(0\)\
\-\ \\ \\ \\ \\ renal\\ tubular\\ acidosis\\,\\ type\\ i\\ \\(distal\\ form\\)\ \(0\)\
\-\ \\ \\ \\ \\ hyperparathyroidism\\ \\(hypercalciuria\\,\\ hypercalcemia\\)\ \(0\)\
\-\ \\ \\ \\ \\ medullary\\ sponge\\ kidney\ \(0\)\
\-\ \\ \\ \\ \\ hypercalcemic\\/hypercalciuric\\ states\ \(0\)\
\-\ \\ \\ \\ \\ papillary\\ necrosis\ \(0\)\
\-\ \\ \\ \\ \\ nephrotoxic\\ drugs\\ \\(amphotericin\\ b\\)\ \(0\)\
\-\ \\ \\ \\ \\ furosemide\\ treatment\\ of\\ the\\ newborn\ \(0\)\
\-\ \\ \\ \\ \\ chronic\\ pyelonephritis\ \(0\)\
\-\ \\ \\ \\ \\ milk\\-alkali\\ syndrome\ \(0\)\
\-\ \\ \\ \\ \\ hypervitaminosis\\ d\ \(0\)\
\-\ eleven\\-year\\-old\\ female\\ with\\ history\\ of\\ hypertension\\.\ \(0\)\
\-\ the\\ laboratory\\ data\\ is\\ extensive\\ and\\ suggests\\ multiple\\ underlying\\ disorders\\ for\\ this\\ patient\\ who\\ was\\ ultimately\\ diagnosed\\ with\\ autonomous\\ polyglandular\\ disorder\\,\\ type\\ i\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mg\\:\\ 0\\.40937971028262266\ \(0\)\
\-\ ca\\:\\ 0\\.1818783374451876\ \(0\)\
\-\ nephrocalcinosis\\:\\ 0\\.1552806951165848\ \(0\)\
\-\ ml\\:\\ 0\\.1543160951521994\ \(0\)\
\-\ medullary\\:\\ 0\\.15082646738884545\ \(0\)\
\-\ ua\\:\\ 0\\.12211648162508389\ \(0\)\
\-\ hpf\\:\\ 0\\.10528110383360297\ \(0\)\
\-\ sec\\:\\ 0\\.10194551688523694\ \(0\)\
\-\ kidney\\:\\ 0\\.08985771124625742\ \(0\)\
\-\ 98\\:\\ 0\\.08259171967044913\ \(0\)\
\-\ glucose\\:\\ 0\\.0823883401187929\ \(0\)\
\-\ underlying\\:\\ 0\\.0696078042021032\ \(0\)\
\-\ 499\\:\\ 0\\.06818247106585762\ \(0\)\
\-\ cortcotpn\\:\\ 0\\.06818247106585762\ \(0\)\
\-\ of\\:\\ 0\\.06674767440265297\ \(0\)\
\-\ 1225\\:\\ 0\\.06515199110204499\ \(0\)\
\-\ 339\\:\\ 0\\.06300183134950557\ \(0\)\
\-\ polyglandular\\:\\ 0\\.06300183134950557\ \(0\)\
\-\ 24h\\:\\ 0\\.06133403787532256\ \(0\)\
\-\ nephrotoxic\\:\\ 0\\.06133403787532256\ \(0\)\
\-\ oxalate\\:\\ 0\\.05997135138569294\ \(0\)\
\-\ hypercalciuria\\:\\ 0\\.05997135138569294\ \(0\)\
\-\ ionized\\:\\ 0\\.058819216375101645\ \(0\)\
\-\ 307\\:\\ 0\\.058819216375101645\ \(0\)\
\-\ autonomous\\:\\ 0\\.058819216375101645\ \(0\)\
\-\ prot\\:\\ 0\\.05782119163315353\ \(0\)\
\-\ vit\\:\\ 0\\.05782119163315353\ \(0\)\
\-\ hypervitaminosis\\:\\ 0\\.05782119163315353\ \(0\)\
\-\ 15\\:\\ 0\\.057620121509618066\ \(0\)\
\-\ type\\:\\ 0\\.057202229413213075\ \(0\)\
\-\ furosemide\\:\\ 0\\.05615339815897051\ \(0\)\
\-\ ultrasonographic\\:\\ 0\\.055441041942693246\ \(0\)\
\-\ phosphorus\\:\\ 0\\.054790711669340894\ \(0\)\
\-\ 117\\:\\ 0\\.054790711669340894\ \(0\)\
\-\ creat\\:\\ 0\\.054192465810441355\ \(0\)\
\-\ amphotericin\\:\\ 0\\.054192465810441355\ \(0\)\
\-\ 132\\:\\ 0\\.05312291819515788\ \(0\)\
\-\ crystals\\:\\ 0\\.05312291819515788\ \(0\)\
\-\ pyramids\\:\\ 0\\.05312291819515788\ \(0\)\
\-\ renal\\:\\ 0\\.053099901762325485\ \(0\)\
\-\ ketones\\:\\ 0\\.05264055191680148\ \(0\)\
\-\ micro\\:\\ 0\\.05264055191680148\ \(0\)\
\-\ sponge\\:\\ 0\\.05176023170552826\ \(0\)\
\-\ 250\\:\\ 0\\.05135612879387924\ \(0\)\
\-\ the\\:\\ 0\\.051043232731367356\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.04992816605328156\ \(0\)\
\-\ ft4\\:\\ 0\\.04961007195298885\ \(0\)\
\-\ ptt\\:\\ 0\\.048729751741715635\ \(0\)\
\-\ acidosis\\:\\ 0\\.04845793694239755\ \(0\)\
\-\ co2\\:\\ 0\\.04745991220044944\ \(0\)\
\-\ 103\\:\\ 0\\.04700679873136294\ \(0\)\
\-\ 140\\:\\ 0\\.046790143468214536\ \(0\)\
\-\ ldh\\:\\ 0\\.046374809775748496\ \(0\)\
\-\ neg\\:\\ 0\\.04598134613027667\ \(0\)\
\-\ amylase\\:\\ 0\\.04525158808255869\ \(0\)\
\-\ thinning\\:\\ 0\\.04525158808255869\ \(0\)\
\-\ alk\\:\\ 0\\.0445867871692022\ \(0\)\
\-\ ultimately\\:\\ 0\\.0445867871692022\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.044275321967993615\ \(0\)\
\-\ phos\\:\\ 0\\.0441243252520834\ \(0\)\
\-\ scarring\\:\\ 0\\.0439763187675503\ \(0\)\
\-\ rbc\\:\\ 0\\.04288725656356341\ \(0\)\
\-\ specifically\\:\\ 0\\.04288725656356341\ \(0\)\
\-\ drugs\\:\\ 0\\.04263809738397939\ \(0\)\
\-\ newborn\\:\\ 0\\.042049282546176514\ \(0\)\
\-\ 67\\:\\ 0\\.0419368881991903\ \(0\)\
\-\ data\\:\\ 0\\.04182615901501089\ \(0\)\
\-\ hgb\\:\\ 0\\.041398952272824176\ \(0\)\
\-\ tsh\\:\\ 0\\.04119417005939645\ \(0\)\
\-\ bun\\:\\ 0\\.041093845288270765\ \(0\)\
\-\ shadowing\\:\\ 0\\.041093845288270765\ \(0\)\
\-\ alt\\:\\ 0\\.04099484936117515\ \(0\)\
\-\ ast\\:\\ 0\\.04089714753558522\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.040611479009914374\ \(0\)\
\-\ hct\\:\\ 0\\.04042692436831166\ \(0\)\
\-\ 57\\:\\ 0\\.04024681726223287\ \(0\)\
\-\ papillary\\:\\ 0\\.039731158798641156\ \(0\)\
\-\ diffusely\\:\\ 0\\.03964857140333333\ \(0\)\
\-\ suggests\\:\\ 0\\.039327055886992125\ \(0\)\
\-\ echogenic\\:\\ 0\\.039094682251641574\ \(0\)\
\-\ contour\\:\\ 0\\.03836847230901154\ \(0\)\
\-\ observed\\:\\ 0\\.037964369397362516\ \(0\)\
\-\ disorders\\:\\ 0\\.037643544040606956\ \(0\)\
\-\ states\\:\\ 0\\.03745745766762735\ \(0\)\
\-\ form\\:\\ 0\\.037275892061548334\ \(0\)\
\-\ tubular\\:\\ 0\\.037040468402394014\ \(0\)\
\-\ subtle\\:\\ 0\\.03675624848283826\ \(0\)\
\-\ hr\\:\\ 0\\.03664551929865885\ \(0\)\
\-\ disorder\\:\\ 0\\.03606420228782894\ \(0\)\
\-\ indicated\\:\\ 0\\.035066177545880824\ \(0\)\
\-\ is\\:\\ 0\\.03502756302567421\ \(0\)\
\-\ total\\:\\ 0\\.03493388943354988\ \(0\)\
\-\ normal\\:\\ 0\\.034815079576679404\ \(0\)\
\-\ caused\\:\\ 0\\.034185857334607606\ \(0\)\
\-\ limits\\:\\ 0\\.03368867621844243\ \(0\)\
\-\ extensive\\:\\ 0\\.03284958106054082\ \(0\)\
\-\ sagittal\\:\\ 0\\.03278372968101047\ \(0\)\
\-\ hypertension\\:\\ 0\\.03262159570442823\ \(0\)\
\-\ necrosis\\:\\ 0\\.03258958673375995\ \(0\)\
\-\ 13\\:\\ 0\\.03215528546495852\ \(0\)\
\-\ 11\\:\\ 0\\.031917993051393305\ \(0\)\
\-\ management\\:\\ 0\\.031492408465095184\ \(0\)\
\-\ laboratory\\:\\ 0\\.030960220507348445\ \(0\)\
\-\ diagnosed\\:\\ 0\\.03088356257147689\ \(0\)\
\-\ pt\\:\\ 0\\.030682903990279245\ \(0\)\
\-\ cortical\\:\\ 0\\.03060902447709228\ \(0\)\
\-\ wbc\\:\\ 0\\.03013431999666713\ \(0\)\
\-\ this\\:\\ 0\\.02930023212560561\ \(0\)\
\-\ cause\\:\\ 0\\.02904486802014606\ \(0\)\
\-\ size\\:\\ 0\\.028868074628698105\ \(0\)\
\-\ right\\:\\ 0\\.028270460308398724\ \(0\)\
\-\ finding\\:\\ 0\\.028024514050287892\ \(0\)\
\-\ medical\\:\\ 0\\.027096178234923253\ \(0\)\
\-\ for\\:\\ 0\\.025844616018484097\ \(0\)\
\-\ syndrome\\:\\ 0\\.025702922855124846\ \(0\)\
\-\ chronic\\:\\ 0\\.025306852274423454\ \(0\)\
\-\ with\\:\\ 0\\.0250453335458263\ \(0\)\
\-\ distal\\:\\ 0\\.024771930699067093\ \(0\)\
\-\ evidence\\:\\ 0\\.024199627536215386\ \(0\)\
\-\ who\\:\\ 0\\.02411692590981566\ \(0\)\
\-\ without\\:\\ 0\\.022488301627836722\ \(0\)\
\-\ imaging\\:\\ 0\\.02240607766075719\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02216469769815522\ \(0\)\
\-\ posterior\\:\\ 0\\.0220468694581753\ \(0\)\
\-\ lower\\:\\ 0\\.021786475469171604\ \(0\)\
\-\ multiple\\:\\ 0\\.02085365270121898\ \(0\)\
\-\ female\\:\\ 0\\.020573300969816386\ \(0\)\
\-\ treatment\\:\\ 0\\.020309260479937658\ \(0\)\
\-\ images\\:\\ 0\\.019721475201090532\ \(0\)\
\-\ by\\:\\ 0\\.018105247089780025\ \(0\)\
\-\ history\\:\\ 0\\.016288996219584333\ \(0\)\
\-\ at\\:\\ 0\\.016103737770529956\ \(0\)\
\-\ was\\:\\ 0\\.014858681338473753\ \(0\)\
\-\ or\\:\\ 0\\.014831919126054156\ \(0\)\
\-\ patient\\:\\ 0\\.01386698946080494\ \(0\)\
\-\ no\\:\\ 0\\.013864381160925945\ \(0\)\
\-\ and\\:\\ 0\\.008809978081934936\ \(0\)\
